COVID-19: Yet another coronavirus challenge in transplantation

Journal of Heart and Lung Transplantation

Volumn 39, Issue 5, 2020, Pages 408-409

  Aslam, Saima ^a   Mehra, Mandeep R ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; CHLOROQUINE; CORTICOSTEROID; GANCICLOVIR; HYPERIMMUNE GLOBULIN; IMMUNOGLOBULIN; INTERFERON; LOPINAVIR PLUS RITONAVIR; QUINOLINE DERIVED ANTIINFECTIVE AGENT; REMDESIVIR; RIBAVIRIN;

CARDIAC GRAFT REJECTION; CORONAVIRUS DISEASE 2019; DISEASE SEVERITY; DRUG MEGADOSE; EDITORIAL; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION CONTROL; INFECTION RATE; MIDDLE EAST RESPIRATORY SYNDROME; MORTALITY RATE; ORGAN TRANSPLANTATION; PLASMA; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SEVERE ACUTE RESPIRATORY SYNDROME; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; VIRUS SHEDDING; VIRUS TRANSMISSION; BETACORONAVIRUS; CONSENSUS; CORONAVIRINAE; CORONAVIRUS INFECTION; DONOR; HEPACIVIRUS; PANDEMIC; VIRUS PNEUMONIA;

BETACORONAVIRUS; CONSENSUS; CORONAVIRUS; CORONAVIRUS INFECTIONS; HEPACIVIRUS; HUMANS; PANDEMICS; PNEUMONIA, VIRAL; TISSUE DONORS;

EID: 85083067710     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2020.03.007     Document Type: Editorial

References (14)

1. World Health Organization. Rolling updates on coronavirus disease (COVID-19). Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen.
2. Centers for Disease Control and Prevention. Coronavirus Disease 2019 (COVID-19) in the U.S. Available at: https://www.cdc.gov/coronavirus/2019-ncov/cases-in-us.html.
3. Li, Q, Guan, X, Wu, P, et al. Early transmission dynamics in Wuhan,China, of novel coronavirus–infected pneumonia. N Engl J Med 382 (2020), 1199–1207.
4. Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2020 in China. [e-pub ahead of print]. N Engl J Med. doi:10.1056/NEJMoa2002032. Accessed March 11, 2020. PMID:32109013.
5. Wu Z, McGoogan JM.Characteristics of and important lessons from the coronavirus Disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. [e-pub ahead of print]. JAMA. doi:10.1001/jama.2020.2648. Accessed March 11, 2020. PMID:32091533.
6. Liang, W, Guan, W, Chen, R, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 21 (2020), 335–337.
7. Li, F, Cai, J, Dong, N, First cases of COVID-19 in heart transplantation From China. J Heart Lung Transplant 39 (2020), 418–419.
8. Tikellis, C, Thomas, MC, Angiotensin-converting enzyme 2 (ACE2) is a key modulator of the renin angiotensin system in health and disease. Int J Pept, 2012, 2012, 256294.
9. Hu Z, Song C, Xu C, et al. Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China. [e-pub ahead of print]. Sci China Life Sci. doi:10.1007/s11427-020-1661-4. Accessed March 11, 2020. PMID: 32146694.
10. Kam KQ, Yung CF, Cui L, et al. A well infant with coronavirus Disease 2019 (COVID-19) with high viral load.[e-pub ahead of print]. Clin Infect Dis. doi:10.1093/cid/ciaa201. Accessed March 11, 2020. PMID:32112082.
11. Ong SWX, Tan YK, Chia PY, et al. Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient. [e-pub ahead of print]. JAMA. doi:10.1001/jama.2020.3227. Accessed March 11, 2020. PMID: 32129805.
12. Dong, L, Hu, S, Gao, J, Discovering drugs to treat coronavirus disease 2019 (COVID-19). Drug Discov Ther 14 (2020), 58–60.
13. Wang, M, Cao, R, Zhang, L, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 30 (2020), 269–271.
14. Mair-Jenkins, J, Saavedra-Campos, M, Baillie, JK, et al. The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis. J Infect Dis 211 (2015), 80–90.